PILL holdings: all 66 positions
PILL held swaps on SPSIPH worth 230.8% of its net assets on Oct 22, 2026. With the 69.2% it holds directly, its exposure is 300.0%.
Every position
| # | Holding | Weight ↓ |
|---|---|---|
| 1 | SPSIPH swap asset leg | 109.65% |
| 2 | SPSIPH swap asset leg | 56.97% |
| 3 | SPSIPH swap asset leg | 54.83% |
| 4 | SPSIPH swap asset leg | 9.32% |
| 5 | Xeris Biopharma Holdings Inc | 1.96% |
| 6 | Veradermics Inc | 1.94% |
| 7 | Pacira Biosciences Inc | 1.76% |
| 8 | Amneal Pharmaceuticals Inc | 1.65% |
| 9 | ELI Lilly & Co | 1.61% |
| 10 | Maze Therapeutics Inc | 1.61% |
| 11 | Perrigo Co PLC | 1.59% |
| 12 | Viatris Inc | 1.56% |
| 13 | Zoetis Inc | 1.56% |
| 14 | Pfizer Inc | 1.52% |
| 15 | Ligand Pharmaceuticals | 1.49% |
| 16 | Royalty Pharma PLC- Cl A | 1.47% |
| 17 | ANI Pharmaceuticals Inc | 1.45% |
| 18 | Indivior Pharmaceuticals Inc | 1.42% |
| 19 | Prestige Consumer Healthcare | 1.42% |
| 20 | Septerna Inc | 1.40% |
| 21 | Organon & Co | 1.40% |
| 22 | Johnson & Johnson | 1.39% |
| 23 | Supernus Pharmaceuticals Inc | 1.39% |
| 24 | Merck & Co. Inc. | 1.39% |
| 25 | Innoviva Inc | 1.39% |
| 26 | Collegium Pharmaceutical Inc | 1.37% |
| 27 | Bristol-Myers Squibb Co | 1.36% |
| 28 | Elanco Animal Health Inc | 1.34% |
| 29 | Definium Therapeutics, Inc | 1.32% |
| 30 | Corcept Therapeutics Inc | 1.29% |
| 31 | Edgewise Therapeutics Inc | 1.28% |
| 32 | Jazz Pharmaceuticals PLC | 1.24% |
| 33 | Amylyx Pharmaceuticals Inc | 1.23% |
| 34 | Tarsus Pharmaceuticals Inc | 1.21% |
| 35 | Omeros Corp | 1.21% |
| 36 | Harmony Biosciences Holdings | 1.21% |
| 37 | Eton Pharmaceuticals Inc | 1.18% |
| 38 | MBX Biosciences Inc | 1.12% |
| 39 | Amphastar Pharmaceuticals in | 1.09% |
| 40 | Trevi Therapeutics Inc | 1.08% |
| 41 | Harrow Inc | 1.04% |
| 42 | Axsome Therapeutics Inc | 1.03% |
| 43 | Enliven Therapeutics Inc | 1.02% |
| 44 | Zevra Therapeutics Inc | 1.02% |
| 45 | Nuvation Bio Inc | 1.00% |
| 46 | LB Pharmaceuticals Inc | 0.99% |
| 47 | Alumis Inc | 0.97% |
| 48 | Cormedix Inc | 0.93% |
| 49 | Phibro Animal Health Corp-A | 0.91% |
| 50 | Wave Life Sciences Inc | 0.87% |
| 51 | Ocular Therapeutix Inc | 0.80% |
| 52 | Liquidia Corp | 0.80% |
| 53 | Rapport Therapeutics Inc | 0.78% |
| 54 | Phathom Pharmaceuticals Inc | 0.77% |
| 55 | Alto Neuroscience Inc | 0.75% |
| 56 | Aquestive Therapeutics Inc | 0.72% |
| 57 | Aclaris Therapeutics Inc | 0.59% |
| 58 | Relmada Therapeutics Inc | 0.58% |
| 59 | Avalyn Pharma Inc | 0.57% |
| 60 | Arvinas Inc | 0.53% |
| 61 | Evolus Inc | 0.47% |
| 62 | Lexicon Pharmaceuticals Inc | 0.45% |
| 63 | Bioage Labs Inc | 0.38% |
| 64 | Contineum Therapeutics Inc-A | 0.28% |
| 65 | Eyepoint Inc | 0.07% |
| 66 | Esperion Therapeutics Inc | 0.00% |
| Goldman Finl Sq Trsry Inst 506 | 19.24% | |
| Dreyfus Govt Cash Man Ins | 5.64% | |
| Goldman Sachs Fin Gov 465 Institut | 5.13% |
Source: Direxion’s daily holdings file. Data as of Oct 22, 2026. Updated each trading day. Report a data error
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. A swap line’s weight is the exposure it gives the fund, not money the fund paid. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. A swap’s Tracks column is the name its line gives what it is written on. Names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of PILL, data as of Oct 22, 2026. https://etfiq.com/funds/pill/holdings/
ETFIQ. (Oct 22, 2026). Holdings of PILL. Retrieved from https://etfiq.com/funds/pill/holdings/
[Holdings of PILL (ETFIQ, Oct 22, 2026)](https://etfiq.com/funds/pill/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.